XML 82 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
12. Derivative Instruments
9 Months Ended
Sep. 30, 2012
Notes to Financial Statements  
Note 12 - Derivative Instruments

Derivative instruments

 

We use derivative financial instruments, including options, futures and swaps as a means of hedging exposure to interest rate, equity price change, equity volatility and foreign currency risk. This includes our surplus hedge which utilizes futures and options to hedge against declines in equity markets and the resulting statutory capital and surplus impact. We also use derivative instruments to economically hedge our exposure on living benefits offered on certain of our variable annuity products as well as index credits on our fixed indexed annuity products.

 

The Company seeks to enter into over-the-counter (“OTC”) derivative transactions pursuant to master agreements that provide for a netting of payments and receipts by counterparty. As of September 30, 2012 and December 31, 2011, $9.3 million and $8.0 million, respectively, of cash and cash equivalents were held as collateral by a third party related to our derivative transactions.

 

Our derivatives do not qualify for hedge accounting. We do not designate the purchased derivatives related to variable annuity living benefits or fixed indexed annuity index credits as hedges for accounting purposes.

 

Derivative Instruments:               Fair Value as of  
($ in millions)         Notional     September 30, 2012  
    Maturity     Amount     Assets     Liabilities(1)  
                         
Interest rate swaps   2016-2027     $ 180.0     $ 16.8     $ 8.2  
Variance swaps   2015-2017       0.9             3.1  
Swaptions   2024       25.0              
Put options   2015-2022       406.0       80.9        
Call options(2)   2013-2017       1,261.7       77.4       48.7  
Cross currency swaps   2016       10.0       0.2        
Equity futures   2013       184.2       19.8        
Total derivative instruments         $ 2,067.8     $ 195.1     $ 60.0  

———————

(1) Derivative liabilities are included in other liabilities on the consolidated balance sheets.
(2) Includes a contingent receivable of $3.5 million.

 

Derivative Instruments:               Fair Value as of  
($ in millions)               December 31, 2011  
          Notional     As restated and amended  
    Maturity     Amount     Assets     Liabilities(1)  
                         
Interest rate swaps   2017-2026     $ 131.0     $ 13.7     $ 5.2  
Variance swaps   2015-2017       0.9       2.8        
Swaptions   2024       25.0       0.2        
Put options   2015-2022       406.0       95.4        
Call options(2)   2012-2016       700.4       31.4       19.0  
Cross currency swaps   2012-2016       15.0       0.2        
Equity futures   2012       70.0       18.5        
Total derivative instruments         $ 1,348.3     $ 162.2     $ 24.2  

———————

(1) Derivative liabilities are included in other liabilities on the consolidated balance sheets.
(2) Includes a contingent receivable of $3.4 million.

 

Derivative Instrument Gains (Losses) Recognized in   Three Months Ended     Nine Months Ended  
Realized Investment Gains (Losses):   September 30,     September 30,  
($ in millions)   2012     2011     2012     2011  
          As restated and amended           As restated and amended  
                         
Interest rate swaps   $ (0.4 )   $ 9.0     $ 0.5     $ 10.5  
Variance swaps     (1.8 )     5.1       (6.4 )     3.5  
Swaptions           (0.4 )     (0.2 )     (1.3 )
Put options     (8.4 )     32.9       (14.6 )     24.3  
Call options     7.4       (11.0 )     7.6       (11.0 )
Equity futures     (11.1 )     15.6       (20.5 )     9.9  
Cross currency swaps     0.1       1.1       0.2       (0.2 )
Embedded derivatives     7.1       (50.5 )     6.9       (42.9 )
Total derivative instrument losses recognized in realized investment gains (losses)   $ (7.1 )   $ 1.8     $ (26.5 )   $ (7.2 )

 

Contingent features

 

In certain derivative counterparty agreements, our financial strength ratings are below the specified threshold levels. However, the Company held no derivative instruments as of September 30, 2012 in a net aggregate liability position payable to any counterparty (i.e., such derivative instruments have fair values in a net asset position payable to the Company if such holdings were liquidated).